Supporting  
  
      healthcare professionals
      healthcare systems
      patients
      life science companies

Unlocking the full potential of cancer care through transformative insights.

Cancer therapy affects everyone in a unique way

The better we understand our health and tolerance to therapy, the more effectively we can mitigate side effects and increase the overall effectiveness of treatment.

Through unique remote patient monitoring solutions and analytics, we're working to deliver more personalised treatment decisions that increase the likelihood of a longer and healthier life.

Unlock preventative, proactive cancer care with Liberty

Liberty comprises an innovative range of oncology remote patient monitoring and analytics solutions designed to enhance home-based care management, prevent unplanned hospitalisations stemming from treatment side effects and enable patients to remain on treatment longer.

Blood count analyser

Symptoms & PROMs

Vitals monitoring

Data analytics

Healthcare Professional Dashboard

Our partners

Care where patients want it

Liberty empowers patients with greater independence whilst also offering valuable reassurance as their care team closely monitors their health during therapy.

Liberty offers unparalleled insight into a patients health during cancer therapy:

The world's first at-home full blood count analyser
Symptoms and PROMs reporting
Vitals monitoring

Machine Learning for risk stratification

Liberty's longitudinal monitoring and machine-learning driven analysis support healthcare professionals with real-time insights for early detection and prevention of serious adverse events.

Our proprietary artificial intelligence analytics deliver insights directly to your Liberty dashboard.

Easily spot potential issues and critical patients at a glance, so your team can make faster, more confident clinical decisions. All of which can mean fewer, less severe adverse events.

For healthcare providers

Early interventions driven by unique insights

Access to more frequent, comprehensive health data whilst a patient is on therapy enables earlier and more informed decisions that can reduce serious complications.

Enhancing care management

Liberty is able to fit seamlessly into existing care management and virtual ward programmes.

Supporting high-value interactions

Liberty provides healthcare professionals with the context they need to have more high-value interactions with patients and tailor their patient's care more effectively.

For life science companies

Enhanced patient support programs

Liberty helps simplify monitoring pathways, empowers patients with greater freedom and offers the reassurance that their health is being monitored throughout treatment.

Increased time on treatment

Proactive management of treatment side effects reduces interruptions and treatment discontinuation meaning patients spend more time on treatment and improved outcomes.

Rich real world evidence capture

Liberty's unique and comprehensive monitoring capabilities allow for rich, high quality insights to be captured in a simple and highly scalable way.

Liberty, a solution you can trust

100%

4.5

100% of patients would recommend Liberty to others [Ref.1]

Average rating out of 5 on ease of collecting a sample [Ref.2]

What our partners and users say about us

“Partnering with digital health and monitoring experts such as Entia will further support Pfizer’s breakthrough therapies in an area where the burden of living with cancer is significant.”

Pfizer
'Financial toxicity is a huge problem for cancer patients so having access to technology like Liberty that could remove the need for some hospital appointments offers real benefits. Working in breast cancer, many of my patients are young women with jobs and families, trying to keep life as normal as possible. I know that having one less appointment to attend makes a real difference to them, taking a lot of stress out of their lives and giving them back a little more time and money.'

Dr Sacha J Howell FRCP PhD
Senior Lecturer and Honorary Consultant in Medical Oncology at The Christie NHS Foundation Trust
“Living with breast cancer, you often feel like your life is a series of medical appointments, and so much is out of your hands. But with the Liberty device, I felt like I had regained a sense of control. Being able to monitor my own blood levels from the comfort of my home was empowering, removing that element of a waiting game to see if I could go ahead with my chemotherapy treatment. I felt that I could focus on what really matters — my family and my own wellbeing. Liberty isn’t just a machine, it’s about managing my health on my own terms.“

Janet, Wrexham
“I have been a nurse in the NHS for over 30 years, so I have seen firsthand the impact of empowering patients to take an active role in their own care. When I was diagnosed with Stage 4 breast cancer, I felt like a small piece of my independence had been taken away. However, when Liberty was introduced into my treatment journey, it made it even easier to manage my health. It’s not just about the ease; it’s about feeling like you are in control of a situation that is often unpredictable. I can’t underestimate the psychological boost that this gives you as a patient.”

Angela, Manchester
“You can be quite fatigued going through certain treatments so it can be really useful having the ability to test at home and knowing that it’s accurate and you don’t need to be going in to the hospital all the time“

Anonymous
"A big challenge given the number of people we are treating in cancer clinics, is that we can’t normally turn around blood tests and provide chemotherapy in the same session. In reality, most patients will end up coming into the clinic at least twice in one week, once for bloods and again if the results are good and they can go ahead with treatment. Liberty could change this by allowing some patients to test at home. This would cut down on appointments for them and help us to save chair space in busy clinics, free up time for nurses and phlebotomists and ultimately allow us to plan treatments more efficiently. It’s an amazing concept."

Professor Peter Schmid, Clinical Director of the Breast Cancer Centre at St. Bartholomew's Hospital and Chair in Cancer Medicine at Barts Cancer Institute, Queen Mary University